Enovix is trading at $2.70, up 5.68%, with no clear company-specific catalyst identified for the September 29 move.
- The latest listed company release was its September 1 defense-battery update.
- The gain follows a 10.98% decline on September 28, but that sequence alone does not establish a cause.
- Broader indices are slightly lower in the supplied market context, so they do not clearly explain Enovixβs rise.